Long-Term Toxicity and Health-Related Quality of Life After Adjuvant Chemoradiation Therapy or Radiation Therapy Alone for High-Risk Endometrial Cancer in the Randomized PORTEC-3 Trial

Author:

Post Cathalijne C.B.,de Boer Stephanie M.,Powell Melanie E.,Mileshkin Linda,Katsaros Dionyssios,Bessette Paul,Haie-Meder Christine,Ottevanger Nelleke (P.) B.,Ledermann Jonathan A.,Khaw Pearly,D'Amico Romerai,Fyles Anthony,Baron Marie Hélène,Kitchener Henry C.,Nijman Hans W.,Lutgens Ludy C.H.W.,Brooks Susan,Jürgenliemk-Schulz Ina M.,Feeney Amanda,Goss Geraldine,Fossati Roldano,Ghatage Prafull,Leary Alexandra,Do Viet,Lissoni Andrea A.,McCormack Mary,Nout Remi A.,Verhoeven-Adema Karen W.,Smit Vincent T.H.B.M.,Putter Hein,Creutzberg Carien L.

Funder

Cancer Research UK

National Health and Medical Research Council

Agenzia Italiana del Farmaco, Ministero della Salute

KWF Kankerbestrijding

Canadian Cancer Society Research Institute

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3